logo
TikTok's Hottest Trend: Jaca Jolt from Healthy For Life Foods Sparks a Viral Sensation

TikTok's Hottest Trend: Jaca Jolt from Healthy For Life Foods Sparks a Viral Sensation

San Diego, CA - As of 3:52 PM PDT today, TikTok has a new breakout star: Jaca Jolt, an all-natural energy shot from the team at Jaca, a brand under Healthy For Life Foods (HFLF). The platform is ablaze with videos of creators and everyday users alike raving about this clean, crash-free energy booster. From relatable skits to personal testimonials, TikTokers are showcasing why Jaca Jolt is quickly becoming their favorite way to Power Their Hour.
Jaca Jolt, sold in a 12-pack of 2 fl oz shots, combines caffeine with essential vitamins B6 and B12 to deliver fast, effective, and long-lasting energy. Its unique formulation is sweetened with Jaca, a 100% pure form of Allulose—a rare sugar with powerful functional benefits. Unlike traditional energy drinks, Jaca Jolt contains no harmful sugar or alternative sweeteners, has zero net carbs, and zero glycemic impact, making it both keto-friendly and diabetic-safe
The star ingredient, Allulose, is GRAS-certified by the FDA (Generally Recognized As Safe) and is associated with a range of health benefits, including support for appetite control and fat burning. With only 5 calories, Jaca Jolt is designed to fit seamlessly into any lifestyle—whether you're at the gym, in meetings, on campus, or managing a full household.
'Jaca Jolt is built for people who live life on the go, and unlike many 2 ounce bottle drinks, is safe for all ages,' said Pete Ferrari, President at Healthy For Life Foods. 'We wanted to create an energy solution that delivers real results—without harmful old school sugar, without excessive amounts of caffeine and other harmful ingredients, without the crash, and without compromise. Seeing our Jaca Jolt go viral on TikTok has been incredibly rewarding. '
The response has been organic and explosive. TikTok videos tagged with #JacaJolt have collectively drawn millions of views. One trending video highlights the caption: 'POV: You're a mom working 12-hour night shifts,' is striking a chord with viewers seeking reliable energy support. Comment sections are filled with praise for its refreshing taste, jitter-free effect, and clean ingredient list. As one user posted, 'Jaca Jolt is a game-changer—no crash, just focus and stamina!'
Whether you're an athlete, a student, a busy parent, or a professional, Jaca Jolt is redefining how we think about energy. It's not just a boost—it's wellness-powered performance.
Jaca Jolt is available now at jacasugar.com. With Healthy For Life Foods leading the charge, this Allulose-powered shot is setting a new standard for energy supplements—and TikTok can't get enough of it.
About Healthy For Life Foods and Jaca Sugar
Healthy For Life Foods is a health and wellbeing company that pioneered the introduction of Allulose—a rare sugar and superfood—to the U.S. market at scale. Through its brand Jaca, HFLF is committed to creating innovative and functional products that support energy, appetite balance, and overall wellness.
Media inquiries at: [email protected]
Jaca (Healthy For Life Foods)
Media Contact
Company Name: Healthy For Life Foods
Contact Person: Pete Ferrari
Email: Send Email
City: Delray Beach
State: FL
Country: United States
Website: https://jacasugar.com/
Source: Reliable PR & Marketing
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

Yahoo

time3 hours ago

  • Yahoo

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

Yahoo

time3 hours ago

  • Yahoo

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

QuasarMD Unveils Advanced Full-Body Light Therapy Mat to Support Aging Wellness
QuasarMD Unveils Advanced Full-Body Light Therapy Mat to Support Aging Wellness

Business Upturn

time3 hours ago

  • Business Upturn

QuasarMD Unveils Advanced Full-Body Light Therapy Mat to Support Aging Wellness

CHINO, Calif., July 29, 2025 (GLOBE NEWSWIRE) — QuasarMD LLC, a leader in light-based wellness technologies, announces the launch of its Full-Body Light Therapy Mat , a clinically validated, non-invasive solution designed to address the evolving wellness needs of aging adults. The full-body mat features 2,052 high-efficiency LEDs delivering dual-wavelength therapy: 660nm red light for surface-level benefits, and 850nm near-infrared (NIR) for deep penetration. Both wavelengths are clinically proven to provide cellular-level therapeutic effects. Specifically designed for aging users, the system provides gentle yet effective relief for common age-related concerns including joint stiffness, muscle fatigue, circulation challenges, and chronic conditions like arthritis or back and knee pain. Designed with Aging in Mind 'Chronic pain, sleepless nights, and reduced mobility are common challenges as we age,' said a spokesperson for QuasarMD. 'Our full-body light therapy mat was specifically developed to help older adults restore their vitality through scientifically validated, non-invasive technology that integrates effortlessly into daily life.' The QuasarMD Full-Body Light Therapy Mat is FDA-cleared device meeting professional-grade standards. Its home operation couldn't be simpler – just lie down and press a button. Featuring an innovative wrap-around design, the mat cossets the body in comfort to ensure complete light exposure from head to toe. Users can easily customize their therapy experience by adjusting time, intensity, and pulse settings for each session. It has a multi-layered fabric design with an inner layer of TPU that enhances light retention, improving both durability and light efficiency. Additionally, it is waterproof and easy to clean, making it convenient for daily use by seniors and caregivers alike. The QuasarMD mat is more than just a health tool – it's a companion for active aging, offering a drug-free, non-invasive way to manage pain, inflammation, and fatigue. Its gentle warmth and therapeutic light not only ease physical discomfort but also enhance mental well-being, improve blood circulation, promote deep relaxation, and foster an enduring sense of vitality – all essential components of healthy aging. 'Today's aging population is more proactive about wellness than ever,' noted the spokesperson. 'Caregivers, wellness professionals, and older adults increasingly demand safe, science-backed solutions that are both effective and convenient for home use. The evidence supporting red and NIR light therapy is robust – and truly empowering.' 'That's why we've developed this solution: to help people naturally manage discomfort, improve sleep quality, and support long-term vitality – all without medications or invasive treatments.' About the Company QuasarMD LLC is a California-based wellness technology company specializing in FDA-cleared light therapy devices that blend clinical efficacy with user-friendly design. Dedicated to working on well-being through the life stages, it has kept innovating non-invasive devices that assist in recovery, wellness, and vigor through light. The Full-Body Light Therapy Mat is now available for purchase at the official QuasarMD shop and through Amazon . Media Contact:QuasarMD LLC Email: [email protected] Phone: 917-426-2860 Address: 15515 Dupont Avenue, Chino, CA 91710, USA Website:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store